Terms: = Ovarian cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
67 results:
1. To study the expression of estrogen, progesterone receptor and p53 immunohistochemistry markers in subtyping endometrial carcinoma.
Yadav A; Sistla A; Swain M; Gowrishankar S; Padua M; Modi T; Himabindu R; Agarwal N; Kulkarni A; Bhandari T; Vudayaraju H; Chinnababu ; Reddy VA
Indian J Pathol Microbiol; 2024; 67(1):62-67. PubMed ID: 38358190
[TBL] [Abstract] [Full Text] [Related]
2. BRCA1, BRCA2, and tp53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With ovarian cancer.
Dobilas A; Chen Y; Brueffer C; Leandersson P; Saal LH; Borgfeldt C
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):763-770. PubMed ID: 38035709
[TBL] [Abstract] [Full Text] [Related]
4. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
5. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
6. Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
Manning-Geist B; Gordhandas S; Hodgson A; Zhou QC; Iasonos A; Chi DS; Ellenson L; Aghajanian CA; Abu-Rustum NR; Leitao M; Long K; Rubinstein MM; Sonoda Y; Alektiar K; Weigelt B; Zivanovic O; Grisham RN
Int J Gynecol Cancer; 2022 Dec; 32(12):1576-1582. PubMed ID: 36368707
[TBL] [Abstract] [Full Text] [Related]
7. Detection of Serous Tubal Intraepithelial Carcinoma along with High Grade Serous Carcinoma of Both Ovaries.
Tariq H
J Coll Physicians Surg Pak; 2021 Sep; 31(9):1108-1110. PubMed ID: 34500532
[TBL] [Abstract] [Full Text] [Related]
8. Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier.
Safdar NS; Thompson EF; Gilks CB; Isacson C; Bennett JA; Clarke B; Young RH; Oliva E
Am J Surg Pathol; 2021 Aug; 45(8):1038-1046. PubMed ID: 34115671
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization in the prediction of disease extent in endometrial carcinoma.
Kolehmainen AM; Pasanen AM; Koivisto-Korander RL; Bützow RC; Loukovaara MJ
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():478-483. PubMed ID: 33189427
[TBL] [Abstract] [Full Text] [Related]
10. The immune complex p53 protein/anti-p53 autoantibodies in the pathogenesis of ovarian serous carcinoma.
Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Smycz-Kubańska M; Englisz A; Strzelczyk J; Kabut J
Ginekol Pol; 2020; 91(9):519-253. PubMed ID: 33030731
[TBL] [Abstract] [Full Text] [Related]
11. CTNNB1 Mutations and Aberrant β-Catenin Expression in ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.
Zyla RE; Olkhov-Mitsel E; Amemiya Y; Bassiouny D; Seth A; Djordjevic B; Nofech-Mozes S; Parra-Herran C
Am J Surg Pathol; 2021 Jan; 45(1):68-76. PubMed ID: 32769429
[TBL] [Abstract] [Full Text] [Related]
12. Endometrial cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid ovarian Carcinoma.
Krämer P; Talhouk A; Brett MA; Chiu DS; Cairns ES; Scheunhage DA; Hammond RFL; Farnell D; Nazeran TM; Grube M; Xia Z; Senz J; Leung S; Feil L; Pasternak J; Dixon K; Hartkopf A; Krämer B; Brucker S; Heitz F; du Bois A; Harter P; Kommoss FKF; Sinn HP; Heublein S; Kommoss F; Vollert HW; Manchanda R; de Kroon CD; Nijman HW; de Bruyn M; Thompson EF; Bashashati A; McAlpine JN; Singh N; Tinker AV; Staebler A; Bosse T; Kommoss S; Köbel M; Anglesio MS
Clin Cancer Res; 2020 Oct; 26(20):5400-5410. PubMed ID: 32737030
[TBL] [Abstract] [Full Text] [Related]
13. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
14. Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level.
Liu H; Zeng SY; Xie Y; Fei CQ; Sun L
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1054-1061. PubMed ID: 32096175
[TBL] [Abstract] [Full Text] [Related]
15. Association of expression of p53, livin, ERCC1, BRCA1 and PARP1 in epithelial ovarian cancer tissue with drug resistance and prognosis.
Zhang Z; Dou X; Yang H; Jia L; Qin K; Gao X; Yang B; Zhang W; Qin C; Zhang F; Shan B
Pathol Res Pract; 2020 Feb; 216(2):152794. PubMed ID: 31902551
[TBL] [Abstract] [Full Text] [Related]
16. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
[TBL] [Abstract] [Full Text] [Related]
17. Apparent Diffusion Coefficient Histogram Analysis for Assessing Tumor staging and Detection of Lymph Node Metastasis in Epithelial ovarian cancer: Correlation with p53 and Ki-67 Expression.
Wang F; Wang Y; Zhou Y; Liu C; Liang D; Xie L; Yao Z; Liu J
Mol Imaging Biol; 2019 Aug; 21(4):731-739. PubMed ID: 30456593
[TBL] [Abstract] [Full Text] [Related]
18. Protein expressions of AIB1, p53 and Bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis.
Liang M; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5134-5139. PubMed ID: 30178833
[TBL] [Abstract] [Full Text] [Related]
19. Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.
Singh N; Faruqi A; Kommoss F; McCluggage WG; Trevisan G; Senz J; Lum A; Gilks CB; Anglesio M
Mod Pathol; 2018 Apr; 31(4):652-659. PubMed ID: 29148539
[TBL] [Abstract] [Full Text] [Related]
20. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
[Next]
